Foghorn Therapeutics: Q4 Earnings Insights

Loading...
Loading...

Foghorn Therapeutics FHTX reported its Q4 earnings results on Thursday, March 7, 2024 at 07:00 AM.

Here's what investors need to know about the announcement.

Earnings

Foghorn Therapeutics beat estimated earnings by 25.0%, reporting an EPS of $-0.57 versus an estimate of $-0.76.

Revenue was up $1.58 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.41 which was followed by a 3.0% drop in the share price the next day.

Here's a look at Foghorn Therapeutics's past performance:

Quarter Q3 2023 Q2 2023 Q1 2023 Q4 2022
EPS Estimate -0.75 -0.73 -0.72 -0.62
EPS Actual -0.34 -0.70 -0.73 -0.69
Revenue Estimate 4.52M 6.26M 5.04M 8.48M
Revenue Actual 17.48M 5.60M 5.31M 4.18M

** Listen to the earnings announcement yourself by clicking here. **

To track all earnings releases for Foghorn Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsBZI-Recaps
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...